We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$252B
AUM Growth
-$7.74B
Cap. Flow
-$10.2B
Cap. Flow %
-4.03%
Top 10 Hldgs %
22.68%
Holding
10,737
New
1,370
Increased
3,710
Reduced
4,352
Closed
1,178

Sector Composition

Rank Sector Weight
1 Technology 2.53%
2 Consumer Discretionary 2.02%
3 Financials 1.63%
4 Healthcare 1.38%
5 Energy 1.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BPZ
9451
DELISTED
BPZ RESOURCES INC COM STK
BPZ
$18K ﹤0.01%
63,762
+12,006
+23% +$10.9K
KWK
9452
CALL
DELISTED
QUICKSILVER RESOURCES INC
KWK
$18K ﹤0.01%
93,200
-14,000
-13% -$6.47K
RSOL
9453
CALL
DELISTED
REAL GOODS SOLAR, INC. CL A COM
RSOL
$17K ﹤0.01%
34,600
-69,900
-67% -$34.3K
CDMO
9454
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$16K ﹤0.01%
1,686
-22,985
-93% -$231K
HQCL
9455
DELISTED
Hanwha Q CELLS Co., Ltd.
HQCL
$16K ﹤0.01%
1,427
-4,178
-75% -$73.6K
MEET
9456
PUT
DELISTED
The Meet Group, Inc. Common Stock
MEET
$16K ﹤0.01%
10,300
-35,800
-78% -$62.3K
KUTV
9457
DELISTED
KU6 MEDIA CO, LTD AMERICAN DEPOSITORY SHARES
KUTV
$16K ﹤0.01%
+15,800
New +$17.9K
ONCT
9458
CALL
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$15K ﹤0.01%
15
-16
-52% -$14.3K
TPI
9459
DELISTED
TIANYIN PHARMACEUTICAL
TPI
$15K ﹤0.01%
+20,000
New +$11K
AMSC icon
9460
CALL
American Superconductor
AMSC
$1.44B
$14K ﹤0.01%
1,930
-1,980
-51% -$20.9K
ZGNX
9461
PUT
DELISTED
Zogenix, Inc.
ZGNX
$14K ﹤0.01%
1,300
-2,888
-69% -$28.6K
OMEX icon
9462
CALL
Odyssey Marine Exploration
OMEX
$54.6M
$13K ﹤0.01%
+1,150
New +$14.6K
HQCL
9463
PUT
DELISTED
Hanwha Q CELLS Co., Ltd.
HQCL
$13K ﹤0.01%
+1,210
New +$21.3K
VPCO
9464
CALL
DELISTED
VAPOR CORP DEL COM STK
VPCO
$13K ﹤0.01%
+2,120
New +$16.7K
DNN icon
9465
PUT
Denison Mines
DNN
$3.37B
$12K ﹤0.01%
12,400
-23,400
-65% -$23.9K
GRCE
9466
Grace Therapeutics
GRCE
$46.3M
$12K ﹤0.01%
+49
New +$12.1K
SES
9467
DELISTED
Synthesis Energy Systems Inc.
SES
$12K ﹤0.01%
+206
New +$13K
TBRA
9468
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$12K ﹤0.01%
+1,514
New +$13K
COCO
9469
DELISTED
CORINTHIAN COLLEGES INC
COCO
$12K ﹤0.01%
194,537
+38,466
+25% +$4.43K
PLM
9470
DELISTED
PolyMet Mining Corp.
PLM
$12K ﹤0.01%
+1,201
New +$12.8K
NAK
9471
PUT
Northern Dynasty Minerals
NAK
$1.01B
$11K ﹤0.01%
28,300
-12,400
-30% -$5.1K
SEEL
9472
PUT
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
HNSN
9473
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$11K ﹤0.01%
2,039
-5,865
-74% -$48.6K
XPL icon
9474
Solitario Resources
XPL
$77M
$10K ﹤0.01%
+10,347
New +$10.4K
HTM
9475
DELISTED
U.S. Geothermal Inc.
HTM
$10K ﹤0.01%
+3,571
New +$10.9K

Similar funds

Jeff Yass's Q4 2014 Portfolio in Review

As of Q4 2014, Jeff Yass held 10,737 positions worth $252B, down 3% from $260B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Jeff Yass withdrew a net $10.2B in Q4 2014, closing 1,178 positions and reducing 4,352 holdings. Its most notable exit was Bausch Health, an estimated $68.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2.2% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in Northern Trust Morningstar Global Upstream Natural Resources ETF worth $31M.

  • Jeff Yass's largest Q4 2014 buy was Northern Trust Morningstar Global Upstream Natural Resources ETF: 1,011,289 shares worth $31M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.22B increase.
  • Jeff Yass's biggest Q4 2014 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.37B.
  • Jeff Yass fully exited Bausch Health in Q4 2014, selling an estimated $68.9M.
  • Jeff Yass's ten largest holdings make up 23% of its $252B portfolio in Q4 2014.
  • Jeff Yass opened 1,370 new positions and closed 1,178 in Q4 2014.
  • Jeff Yass's portfolio value fell 3% quarter-over-quarter to $252B.

Based on Susquehanna International Group's 13F filing for Q4 2014, filed 17 Feb 2015.